CAUTIONARY NOTICE ON ANTI-INFLAMMATORY DRUG TREATMENT OF HORSES

To all trainers 

We would like to highlight crucial information from the NHA Laboratory concerning the detection of sub-therapeutic concentrations of anti-inflammatories in both race day and out-of-competition specimens. Our recent screening analysis has revealed a significant increase in the detection of anti-inflammatories, specifically MELOXICAM, FLUNIXIN, AND FLUMETHASONE, over the past few months compared to other times of the year. It is important to note that these levels remain below the thresholds established by both the NHA and IFHA and are therefore not enforceable at this time. 

In light of these findings, we strongly advise against the indiscriminate use of anti-inflammatories as race day approaches. Any administration of these substances must be justified by a valid clinical diagnosis and conducted in the best interest of the horse's welfare. 

Trainers will be in violation of Rule 10.5.14 if the entries in the Veterinary Treatment Register of your stable do not accurately reflect or indicate the usage of these medications prior to racing. 

Your ongoing commitment to equine welfare and adherence to our regulatory standards is crucial for maintaining the integrity of our sport. 

Any questions or clarification regarding this notice, please contact the NHA Veterinary Department at This email address is being protected from spambots. You need JavaScript enabled to view it. or via WhatsApp on +27 66 471 4527.